19-45364001-C-T
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_000400.4(ERCC2):c.934G>A(p.Asp312Asn) variant causes a missense change. The variant allele was found at a frequency of 0.319 in 1,543,626 control chromosomes in the GnomAD database, including 83,473 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. D312E) has been classified as Uncertain significance.
Frequency
Consequence
NM_000400.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ERCC2 | NM_000400.4 | c.934G>A | p.Asp312Asn | missense_variant | 10/23 | ENST00000391945.10 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ERCC2 | ENST00000391945.10 | c.934G>A | p.Asp312Asn | missense_variant | 10/23 | 1 | NM_000400.4 | P1 |
Frequencies
GnomAD3 genomes ? AF: 0.265 AC: 40248AN: 152048Hom.: 6409 Cov.: 33
GnomAD3 exomes AF: 0.290 AC: 41034AN: 141480Hom.: 6833 AF XY: 0.301 AC XY: 23207AN XY: 77124
GnomAD4 exome AF: 0.325 AC: 452603AN: 1391460Hom.: 77067 Cov.: 54 AF XY: 0.328 AC XY: 225055AN XY: 686616
GnomAD4 genome ? AF: 0.264 AC: 40240AN: 152166Hom.: 6406 Cov.: 33 AF XY: 0.264 AC XY: 19676AN XY: 74394
ClinVar
Submissions by phenotype
not specified Benign:5Other:1
not provided, no classification provided | reference population | ITMI | Sep 19, 2013 | - - |
Benign, no assertion criteria provided | clinical testing | Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen | - | - - |
Likely benign, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Dec 03, 2021 | - - |
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Mar 28, 2016 | Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency, variant associated with cancer risk - |
Benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
Benign, no assertion criteria provided | clinical testing | Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center | - | - - |
Xeroderma pigmentosum, group D Benign:4
Benign, criteria provided, single submitter | clinical testing | Mendelics | May 28, 2019 | - - |
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Mar 06, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. - |
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Jul 30, 2021 | - - |
Benign, criteria provided, single submitter | clinical testing | KCCC/NGS Laboratory, Kuwait Cancer Control Center | Jul 07, 2023 | - - |
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | Invitae | Feb 01, 2024 | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Sep 18, 2018 | This variant is associated with the following publications: (PMID: 27306318, 24841663, 25916209, 24101192, 24933002, 23973729, 29989875, 27153395, 24868140, 11606376, 19041121, 24728327, 21245954, 19242824, 21643959, 19669592, 19055600, 18641418, 22184993, 14630517, 20070155, 19706757) - |
Cerebrooculofacioskeletal syndrome 2 Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Jul 30, 2021 | - - |
Trichothiodystrophy 1, photosensitive Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Jul 30, 2021 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at